Literature DB >> 29589756

Subnanometer Gold Clusters Adhere to Lipid A for Protection against Endotoxin-Induced Sepsis.

Fang-Hsuean Liao1, Te-Haw Wu1, Yu-Ting Huang1, Wen-Jye Lin2, Chun-Jen Su3, U-Ser Jeng3, Shu-Chen Kuo4, Shu-Yi Lin1.   

Abstract

Endotoxicity originating from a dangerous debris (i.e., lipopolysaccharide, LPS) of Gram-negative bacteria is a challenging clinical problem, but no drugs or therapeutic strategies that can successfully address this issue have been identified yet. In this study, we report a subnanometer gold cluster that can efficiently block endotoxin activity to protect against sepsis. The endotoxin blocker consists of a gold nanocluster that serves as a flakelike substrate and a coating of short alkyl motifs that act as an adhesive to dock with LPS by compacting the intramolecular hydrocarbon chain-chain distance ( d-spacing) of lipid A, an endotoxicity active site that can cause overwhelming cytokine induction resulting in sepsis progression. Direct evidence showed the d-spacing values of lipid A to be decreased from 4.19 Å to either 3.85 or 3.54 Å, indicating more dense packing densities in the presence of subnanometer gold clusters. In terms of biological relevance, the concentrations of key pro-inflammatory NF-κB-dependent cytokines, including plasma TNF-α, IL-6, and IL-1β, and CXC chemokines, in LPS-challenged mice showed a noticeable decrease. More importantly, we demonstrated that the treatment of antiendotoxin gold nanoclusters significantly prolonged the survival time in LPS-induced septic mice. The ultrasmall gold nanoclusters could target lipid A of LPS to deactivate endotoxicity by compacting its packing density, which might constitute a potential therapeutic strategy for the early prevention of sepsis caused by Gram-negative bacterial infection.

Entities:  

Keywords:  Endotoxin; inflammation; lipid A; lipopolysaccharide (LPS); sepsis progression; subnanometer gold clusters

Mesh:

Substances:

Year:  2018        PMID: 29589756     DOI: 10.1021/acs.nanolett.7b05464

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  7 in total

1.  Primary Amine Modified Gold Nanodots Regulate Macrophage Function and Antioxidant Response: Potential Therapeutics Targeting of Nrf2.

Authors:  Yueh-Hsia Luo; Hsien-Jen Cheng; Feng-Yuan Tsai; Tsui-Chun Tsou; Shu-Yi Lin; Pinpin Lin
Journal:  Int J Nanomedicine       Date:  2020-10-29

2.  Efficacy of Oxymatrine Plus Antiviral in the Treatment of Sepsis and Its Effect on the Levels of Endotoxin and Inflammatory Factors.

Authors:  Jinglin Zhao; Qi Wei; Shengchao Guo; Hao Wang; Chao Zhao; Caihong Hu; Cuicui Liu; Qingchun Dai; Rui Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-24       Impact factor: 2.650

Review 3.  Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis.

Authors:  Gan Luo; Jue Zhang; Yaqi Sun; Ya Wang; Hanbin Wang; Baoli Cheng; Qiang Shu; Xiangming Fang
Journal:  Nanomicro Lett       Date:  2021-03-08

4.  Secretory leukocyte protease inhibitor suppresses HPV E6-expressing HNSCC progression by mediating NF-κB and Akt pathways.

Authors:  Yu Jin; Yuexiu Li; Xin Wang; Ya Yang
Journal:  Cancer Cell Int       Date:  2019-08-23       Impact factor: 5.722

5.  A Supramolecular Trap to Increase the Antibacterial Activity of Colistin.

Authors:  Fang-Hsuean Liao; Te-Haw Wu; Chun-Nien Yao; Shu-Chen Kuo; Chun-Jen Su; U-Ser Jeng; Shu-Yi Lin
Journal:  Angew Chem Int Ed Engl       Date:  2020-01-07       Impact factor: 15.336

Review 6.  Gold Nanoclusters for Bacterial Detection and Infection Therapy.

Authors:  Mingxiu Tang; Jian Zhang; Chunyan Yang; Youkun Zheng; Hui Jiang
Journal:  Front Chem       Date:  2020-03-24       Impact factor: 5.221

7.  Acute exposure to gold nanoparticles aggravates lipopolysaccharide-induced liver injury by amplifying apoptosis via ROS-mediated macrophage-hepatocyte crosstalk.

Authors:  Yongjun Yang; Shijun Fan; Qian Chen; Yongling Lu; Yuanfeng Zhu; Xiaoli Chen; Lin Xia; Qianying Huang; Jiang Zheng; Xin Liu
Journal:  J Nanobiotechnology       Date:  2022-01-20       Impact factor: 10.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.